Ocular Oncology and Pathology

Scope & Guideline

Your Gateway to Cutting-Edge Ocular Research

Introduction

Welcome to your portal for understanding Ocular Oncology and Pathology, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2296-4681
PublisherKARGER
Support Open AccessNo
CountrySwitzerland
TypeJournal
Convergefrom 2015 to 2024
AbbreviationOCUL ONCOL PATHOL / Ocul. Oncol. Pathol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND

Aims and Scopes

The journal 'Ocular Oncology and Pathology' focuses on advancing knowledge in the field of ocular tumors and associated pathologies. It emphasizes a multidisciplinary approach that integrates clinical, pathological, and imaging methodologies to improve diagnosis, treatment, and understanding of ocular malignancies.
  1. Ocular Tumor Diagnosis and Management:
    The journal covers a wide range of ocular tumors, including uveal melanoma, retinoblastoma, and conjunctival melanoma, focusing on innovative diagnostic techniques and treatment modalities.
  2. Pathological Insights into Ocular Conditions:
    It provides insights into the histopathological features of various ocular tumors, enhancing the understanding of their biological behavior and potential therapeutic targets.
  3. Multimodal Imaging Techniques:
    Research on advanced imaging modalities such as optical coherence tomography and magnetic resonance imaging is emphasized, aiding in the accurate diagnosis and monitoring of ocular tumors.
  4. Therapeutic Innovations:
    The journal highlights new treatment approaches, including brachytherapy, stereotactic radiosurgery, and chemotherapy, aiming to improve patient outcomes and minimize side effects.
  5. Epidemiological and Clinical Studies:
    It publishes studies on the epidemiology, clinical outcomes, and quality of life related to ocular malignancies, contributing to a comprehensive understanding of these diseases.
Recent publications in 'Ocular Oncology and Pathology' reveal several emerging themes that reflect the evolving landscape of ocular oncology research. These trends indicate a shift towards more personalized and precise approaches in the management of ocular tumors.
  1. Targeted Therapies and Personalized Medicine:
    There is an increasing focus on targeted therapies and personalized medicine, particularly in the context of uveal melanoma and retinoblastoma, as researchers seek to tailor treatments based on individual tumor characteristics.
  2. Integration of Genomic and Molecular Data:
    The incorporation of genomic and molecular studies into ocular oncology is on the rise, highlighting the importance of genetic profiling in predicting outcomes and guiding treatment strategies.
  3. Longitudinal Studies on Treatment Outcomes:
    Emerging themes include the need for longitudinal studies that assess long-term outcomes of various treatment modalities, reflecting a growing interest in survivorship and quality of life post-treatment.
  4. Multidisciplinary Approaches to Ocular Tumors:
    There is a notable trend towards multidisciplinary approaches, combining insights from oncology, pathology, radiology, and surgery to improve comprehensive care for patients with ocular tumors.
  5. Exploration of Immunotherapy:
    Research on the role of immunotherapy in the treatment of ocular malignancies is gaining prominence, as there is an increasing interest in harnessing the immune system to combat these cancers.

Declining or Waning

While the journal continues to thrive in several key areas, certain themes appear to be declining in prominence over time. This shift may reflect advancements in treatment and changes in research focus within the field.
  1. Traditional Chemotherapy for Ocular Tumors:
    There is a noticeable decrease in research focusing solely on traditional chemotherapy approaches for ocular tumors, as newer targeted therapies and immunotherapies gain traction in clinical practice.
  2. Non-Invasive Diagnostic Techniques:
    Although still relevant, the emphasis on less invasive diagnostic techniques has diminished, possibly due to the increasing sophistication and accuracy of imaging technologies.
  3. Histopathological Correlation without Clinical Context:
    Research that exclusively discusses histopathological findings without correlating them to clinical outcomes is becoming less common, as there is a growing demand for studies that integrate clinical and pathological data.

Similar Journals

Journal of Ophthalmology

Unlocking New Perspectives in Ophthalmic Studies
Publisher: HINDAWI LTDISSN: 2090-004XFrequency: 1 issue/year

The Journal of Ophthalmology, published by HINDAWI LTD, is an esteemed open-access journal that has been disseminating significant research in the field of ophthalmology since 2009. With an ISSN of 2090-004X and an E-ISSN of 2090-0058, this journal facilitates global access to cutting-edge studies, making it an essential resource for researchers, clinicians, and students alike. Ranked in the Q2 category of ophthalmology for 2023, the journal holds a commendable position with a Scopus rank of #37 out of 137 in its field, placing it in the 73rd percentile. The journal encompasses a variety of topics such as clinical advancements, surgical techniques, and innovative technologies in eye care, aiming to advance scientific knowledge and clinical practice in ophthalmology. By providing a platform for both novel research and comprehensive reviews, the Journal of Ophthalmology is instrumental in fostering collaboration and scholarly communication within the global eye health community, and its commitment to open access ensures that impactful research reaches a wide audience without barriers.

OPHTHALMOLOGICA

Transforming Knowledge into Visionary Practices
Publisher: KARGERISSN: 0030-3755Frequency: 6 issues/year

OPHTHALMOLOGICA is a prestigious journal published by KARGER, dedicated to the dynamic field of ophthalmology and its interdisciplinary connections with medicine and sensory systems. With a rich history spanning over a century since its inception in 1899, this journal is esteemed for its high-quality research and impactful contributions, maintaining an impressive Q1 quartile ranking in both ophthalmology and miscellaneous medicine as of 2023, alongside a notable Q2 status in sensory systems. The journal's influence is reinforced by its Scopus rankings, where it ranks 26th out of 137 in ophthalmology, showcasing a strong percentile position of 81. Based in Basel, Switzerland, OPHTHALMOLOGICA serves as an essential platform for researchers, professionals, and students, providing essential insights, reviews, and studies that push the boundaries of knowledge in the vision sciences. Although it does not currently offer open access, its contributions are critical for those pursuing advancements in ocular health and related disciplines.

Nepalese Journal of Ophthalmology

Illuminating the Path to Better Eye Health
Publisher: NEPAL OPHTHALMIC SOCISSN: 2072-6805Frequency: 2 issues/year

Nepalese Journal of Ophthalmology, established by the NEPAL OPHTHALMIC SOC, is a premier Open Access journal dedicated to advancing the field of ophthalmology. With its ISSN 2072-6805 and E-ISSN 2091-0320, the journal provides an important platform for sharing innovative research and clinical findings in eye health. Since its inception in 2009, the journal has aimed to disseminate high-quality research that addresses contemporary challenges in ophthalmic practices, thus supporting improved patient care and outcomes within Nepal and beyond. The journal has achieved notable recognition, evidenced by its Scopus rank of #267 out of 915 in the field of General Medicine, placing it within the 70th percentile. Researchers, professionals, and students will find valuable information in its comprehensive articles, which cater to a multidisciplinary audience interested in the latest developments in ophthalmology. Emphasizing accessibility, the journal ensures that all published content is freely available, fostering collaboration and knowledge sharing in the global medical community.

International Journal of Ophthalmology

Exploring Breakthroughs in Ophthalmic Education
Publisher: IJO PRESSISSN: 2222-3959Frequency: 12 issues/year

The International Journal of Ophthalmology, with ISSN 2222-3959 and E-ISSN 2227-4898, is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by IJO PRESS in China, this journal has been a valuable resource since its inception in 2005, providing a platform for groundbreaking research and clinical studies in ophthalmic science. With an impressive Q2 ranking in the 2023 Ophthalmology category and a Scopus rank of #65 out of 137, the journal consistently showcases high-quality articles that contribute significantly to the understanding and treatment of eye diseases. Since adopting an open-access model in 2010, it has expanded its reach, allowing researchers, professionals, and students worldwide to access vital knowledge in the field. The journal aims to bridge the gap between laboratory research and clinical practice, making it an essential resource for those committed to improving visual health and advancing ophthalmologic education and innovation.

EUROPEAN JOURNAL OF OPHTHALMOLOGY

Elevating Knowledge in Ophthalmology for Better Outcomes
Publisher: SAGE PUBLICATIONS LTDISSN: 1120-6721Frequency: 6 issues/year

The EUROPEAN JOURNAL OF OPHTHALMOLOGY, published by SAGE PUBLICATIONS LTD, is a leading international journal in the field of ophthalmology, dedicated to advancing the understanding and treatment of ocular diseases and disorders. With an ISSN of 1120-6721 and an E-ISSN of 1724-6016, the journal aims to provide a platform for innovative research, critical reviews, and comprehensive studies that span the diverse aspects of the discipline. As part of its commitment to disseminating high-quality research, the journal is indexed in Scopus, achieving an impressive rank of #47 out of 137 in the Medicine - Ophthalmology category, indicating its strong impact within the academic community. With a current impact factor that places it in the Q2 quartile for both Medicine (miscellaneous) and Ophthalmology as of 2023, it offers researchers and practitioners access to important findings and developments in eye health. The journal's converged years from 1991 to 2024 exemplify its longstanding commitment to the field, making it an essential resource for anyone looking to stay at the forefront of ophthalmological research.

ENDOCRINE PATHOLOGY

Connecting Research and Clinical Excellence in Endocrinology
Publisher: HUMANA PRESS INCISSN: 1046-3976Frequency: 4 issues/year

ENDOCRINE PATHOLOGY is a premier journal published by HUMANA PRESS INC, dedicated to advancing the understanding of endocrine disorders through innovative research and clinical practices. With an impressive impact factor and consistently ranked in the Q1 quartile across multiple categories such as Endocrinology, Diabetes and Metabolism, as well as Pathology and Forensic Medicine, this journal serves as a pivotal resource for researchers and professionals in the field. The journal covers a broad spectrum of topics related to endocrine pathology, providing insights into mechanisms, diagnostics, and therapeutics that inform both clinical and laboratory practices. Although it does not offer open access, its rigorous peer-review process ensures the dissemination of high-quality, impactful research that shapes clinical strategies and enhances patient care. With distribution spanning from its inception in 1990 to 2024, ENDOCRINE PATHOLOGY stands at the forefront of endocrine research, making it an essential read for anyone involved in the study and treatment of endocrine disorders.

Case Reports in Ophthalmology

Connecting professionals with impactful findings.
Publisher: KARGERISSN: 1663-2699Frequency: 3 issues/year

Case Reports in Ophthalmology is an esteemed peer-reviewed journal published by KARGER, dedicated to advancing the field of ophthalmology through the dissemination of high-quality case reports. Since its establishment in 2010, the journal has maintained its Open Access model, ensuring that valuable research is accessible to a global audience, thus fostering collaboration and innovation in eye care. Hailing from Switzerland, the journal covers a broad range of topics within ophthalmology, providing a platform for clinicians and researchers to share unique clinical insights and pivotal findings. With a current impact factor that positions it within the Q3 category of ophthalmology in the 2023 rankings, Case Reports in Ophthalmology is a vital resource for professionals seeking to stay abreast of emerging trends and case studies in the field. Researchers and students alike will benefit from its rigorous peer-review process and its commitment to supporting quality research initiatives, making it an essential addition to any ophthalmology library.

Turk Oftalmoloji Dergisi-Turkish Journal of Ophthalmology

Pioneering Discoveries in Eye Health
Publisher: GALENOS PUBL HOUSEISSN: 1300-0659Frequency: 6 issues/year

Turk Oftalmoloji Dergisi - Turkish Journal of Ophthalmology is a premier peer-reviewed publication dedicated to the field of ophthalmology, published by GALENOS PUBL HOUSE. Since its inception in 1997, this Open Access journal has championed the dissemination of high-quality research, fostering an inclusive environment for sharing knowledge and advancements in eye health. With an ISSN of 1300-0659 and an E-ISSN of 2147-2661, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest findings and innovations in ophthalmic sciences. Although its coverage in Scopus has been discontinued since 2017, the journal has garnered a significant rank of 80 out of 114 in the field of Medicine – Ophthalmology, highlighting its relevance and impact within the discipline. Operating out of Istanbul, Turkey, the Turkish Journal of Ophthalmology continues to be a crucial platform for ophthalmologists and researchers to publish their work and advance the understanding of ocular health.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Pioneering Research for Better Vision
Publisher: SPRINGERISSN: 0721-832XFrequency: 12 issues/year

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, published by Springer, has established itself as a premier journal in the field of ophthalmology since its inception in 1870. With an ISSN of 0721-832X and an E-ISSN of 1435-702X, this esteemed journal enjoys a notable impact in the research community, ranking Q1 in Ophthalmology and Q1 in Sensory Systems, as per the latest 2023 journal category quartiles. GRAEFES Archive is dedicated to advancing our understanding of ocular health through both clinical and experimental studies, making it an essential resource for researchers, practitioners, and students alike. Its comprehensive scope covers various aspects of ophthalmic science, reflecting its long-standing commitment to quality and excellence. Although it currently operates on a subscription basis, the journal's significant Scopus rankings—24th out of 137 in Ophthalmology—underscore its relevance and influence within the scientific community. Situated in Germany, with its address in the United States, this international journal continues to shape the discourse on vision science and therapeutic innovation.

CURRENT EYE RESEARCH

Illuminating Innovations in Eye Health
Publisher: TAYLOR & FRANCIS INCISSN: 0271-3683Frequency: 12 issues/year

CURRENT EYE RESEARCH is a prestigious academic journal published by Taylor & Francis Inc, focusing on advancing the field of ophthalmology and its intersection with cellular and molecular neuroscience. Since its inception in 1981, this journal has provided a vital platform for original research, reviews, and technical notes, presenting a wealth of knowledge to practitioners and researchers alike. With an impressive 2023 impact factor reflected in its ranking of Q2 in Ophthalmology and Q2 in Sensory Systems, and a Q3 ranking in Cellular and Molecular Neuroscience, CURRENT EYE RESEARCH plays a crucial role in fostering interdisciplinary collaboration and innovation. The journal is indexed in Scopus, where it holds strong positions in both the Medicine and Neuroscience categories, enhancing its visibility and reach. Researchers and professionals in these fields can access cutting-edge findings and contribute to the ongoing discourse surrounding eye health, making it an essential resource for anyone invested in advancing knowledge and treatment in ophthalmic science.